GGrantIndex
← Leaderboards

Liya Pi

Tulane University Of Louisiana

$2,424,533
Attributed
$2,424,533
Total exposure
2
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $500.8K · FY201624
$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$2,424,533 · 2

By mechanism

R01$1,699,248 · 1
K01$725,285 · 1

Top collaborators

No co-investigators on record.

Most similar at Tulane University Of Louisiana

Same institution · by research overlap

Others in their field

Top investigators on “Hepatitis

Research focus

HepatitisHepatic Stellate CellFda ApprovedGenesHepaticHepatic FibrogenesisChronic Liver DiseaseEnhancersFibrosisFollow-UpAffectDiagnosisDesignConnective Tissue Growth FactorAlcoholic Liver DiseasesChronicBindingAlcoholsAmericanCicatrixCirrhosisCellsCell Surface ProteinsHepatocyte

Grant awards (11)

Regulation of the pro-fibrotic connective tissue growth factor in alcoholic liver disease: mechanisms and targeting approaches$333,189
R01 · FY2024 · AA · contact PI
Regulation of the pro-fibrotic connective tissue growth factor in alcoholic liver disease: mechanisms and targeting approaches$333,189
R01 · FY2023 · AA · contact PI
Regulation of the pro-fibrotic connective tissue growth factor in alcoholic liver disease: mechanisms and targeting approaches$333,189
R01 · FY2022 · AA · contact PI
Regulation of the pro-fibrotic connective tissue growth factor in alcoholic liver disease: mechanisms and targeting approaches$233,494
R01 · FY2021 · AA · contact PI
Regulation of the pro-fibrotic connective tissue growth factor in alcoholic liver disease: mechanisms and targeting approaches$110,440
R01 · FY2021 · AA · contact PI
Regulation of the pro-fibrotic connective tissue growth factor in alcoholic liver disease: mechanisms and targeting approaches$355,747
R01 · FY2020 · AA · contact PI
Connective tissue growth factor: an intriguing therapeutic target in alcoholic liver disease$145,057
K01 · FY2020 · AA · contact PI
Connective tissue growth factor: an intriguing therapeutic target in alcoholic liver disease$145,057
K01 · FY2019 · AA · contact PI
Connective tissue growth factor: an intriguing therapeutic target in alcoholic liver disease$145,057
K01 · FY2018 · AA · contact PI
Connective tissue growth factor: an intriguing therapeutic target in alcoholic liver disease$145,057
K01 · FY2017 · AA · contact PI
Connective tissue growth factor: an intriguing therapeutic target in alcoholic liver disease$145,057
K01 · FY2016 · AA · contact PI